COMMUNIQUÉS West-GlobeNewswire

AMN Healthcare Announces Third Quarter 2025 Results
06/11/2025
Quarterly revenue of $634 million and adjusted EBITDA of $58 million ; GAAP income of $0.76 /share and adjusted EPS of $0.39 DALLAS, Nov. 06, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the [...]
Certara Reports Third Quarter 2025 Financial Results
06/11/2025
Updates Full Year 2025 Financial Guidance RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the [...]
Precision Optics Schedules First Quarter of Fiscal Year 2026 Conference Call for November 13, 2025
06/11/2025
GARDNER, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
06/11/2025
Topline Phase 3 CATT1 data for cadisegliatin in type 1 diabetes expected second half 2026 $80 million private placement strengthens balance sheet and supports Phase 3 CATT1 completion Announced issuance of new U.S. [...]
Codexis Reports Third Quarter 2025 Financial Results
06/11/2025
Announces signing of $37.8m Supply Assurance Agreement with Merck Organizational changes streamline company and reduce operational expenses Cash runway extended through 2027 REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE [...]
Galecto Reports Third Quarter 2025 Operating and Financial Results
06/11/2025
BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its [...]
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
06/11/2025
– Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics – – Completed $60.3 million oversubscribed private placement led by Samsara BioCapital with [...]
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
06/11/2025
ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced [...]
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
06/11/2025
– Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC; Expects to dose first patient before year-end – – Company presented new [...]
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
06/11/2025
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advancement of SL-325 – – Appointments of Dan Baker, M.D [...]
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
06/11/2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective November 1, 2025, in [...]
Sotera Health Announces Secondary Offering of Common Stock
06/11/2025
CLEVELAND, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 30,000,000 shares of its common stock, par value $0 [...]
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
06/11/2025
First participant dosed in Phase 1 trial of BGE-102, oral CNS-penetrant NLRP3 inhibitor, with initial SAD data expected by year-end Continued advancement of oral and parenteral APJ agonist programs targeting 2026 IND [...]
Best Vascular/Novoste Marks 25 Years Since FDA Approval of Vascular Brachytherapy
06/11/2025
Celebrating a groundbreaking milestone in heart health innovation Washington, D.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- This month marks a major milestone in cardiovascular medicine: 25 years since the U.S. Food and Drug [...]
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
06/11/2025
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that its Cytek ® Muse ® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 [...]
Nova Leap Health Corp. Posts Best Financial Performance in Company History with Record Q3 2025 Results
06/11/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
VitalHub Reports Third Quarter 2025 Results
06/11/2025
Annual Recurring Revenue (ARR)⁽¹⁾ up 75% YoY to $93.7 million Total Revenue up 94% YoY to $32.0 million Adjusted EBITDA⁽¹⁾ up 58% YoY to $7.2 million TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) ( [...]
MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
07/11/2025
LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
07/11/2025
Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration rate (eGFR) of approximately 69 mL/min/1.73 m² Tegoprubart demonstrated a [...]

Pages